Breaks Categories: News

TuesdayMay 20, 2025 9:20 am

NetworkNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Named Exclusive UK and EEA Distributor for ZOLEO Satellite Devices

NextPlat (NASDAQ: NXPL, NXPLW) announced that its subsidiary, Global Telesat Communications Ltd (GTC), has been appointed the exclusive distributor for ZOLEO Inc. across the UK and European Economic Area. ZOLEO's flagship global satellite communicator extends smartphone messaging coverage via the Iridium(R) satellite network and has earned accolades including Outdoor Retailer’s Innovation Award "Product of the Year." The partnership adds to GTC’s expanding e-commerce and Amazon storefront portfolio of satellite connectivity solutions for remote workers, outdoor enthusiasts, and global travelers. To view the full press release, visit: https://nnw.fm/witBH About NextPlat Corp NextPlat is a global e-commerce platform company created to capitalize…

Continue Reading

MondayMay 19, 2025 9:40 am

NetworkNewsBreaks – Intelligent Bio Solutions Inc. (Nasdaq: INBS) Expands Remote Workforce Testing with Fingerprint Drug Screening in Australia

Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company focused on rapid, non-invasive testing, successfully completed a full workforce drug screening for Barcaldine Regional Council in Queensland, Australia, using its Intelligent Fingerprinting Drug Screening System. Over 160 employees were tested and cleared within 90 minutes, significantly reducing operational disruption compared to traditional methods. The on-site, fingerprint-based solution enabled same-day results and supported immediate workforce return, highlighting INBS' growing presence in regional and remote testing markets.  To view the full article, visit https://nnw.fm/zsRvg  About Intelligent Bio Solutions Inc.  Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid,…

Continue Reading

MondayMay 19, 2025 9:00 am

NetworkNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) Reports Q3 Results; Eyes Long-Term Gains with $100M Project Financing

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (CSE: SUNN) posted fiscal Q3 results for the period ended March 31, 2025, showing year-to-date revenue of C$29.1 million versus C$50.4 million a year earlier, reflecting a shift toward long-term asset ownership over short-term EPC sales. The company reported a net loss of C$9 million compared to net income of C$5.5 million last year, driven by higher costs and reduced EPC activity. SolarBank highlighted a 395% increase in assets to C$194 million following the Solar Flow-Through Funds acquisition and secured a mandate letter with CIM Group for up to US$100 million…

Continue Reading

FridayMay 16, 2025 2:25 pm

NetworkNewsBreaks – Capstone Holding Corp. (NASDAQ: CAPS) Reaffirms 2025 Guidance, Highlights M&A Pipeline and Flexible Growth Strategy 

Capstone Holding (NASDAQ: CAPS)  reaffirmed its 2025 targets of a $100 million revenue run-rate and $10 million in adjusted EBITDA, supported by a strong M&A pipeline and disciplined cost control. The company is evaluating acquisition opportunities at 4–6x EBITDA multiples, with up to 45% non-cash consideration, and has secured an equity line of credit to support deals without upfront dilution. Subsidiary Instone remained on track despite seasonal headwinds, with cost run-rate guidance intact and growth expected to pick up in Q3.  To view the full press release, visit https://nnw.fm/r2Ywg  About Capstone Holding Corp.  Capstone Holding Corp. (NASDAQ: CAPS) is a…

Continue Reading

FridayMay 16, 2025 11:48 am

NetworkNewsBreaks – Bionoid Pharma Inc. (OTC PINK: BINP) Rebrands as AI Maverick Intel to Focus on AI-Driven Engagement 

Bionoid Pharma (OTC PINK: BINP)  has rebranded as AI Maverick Intel, Inc., signaling a strategic pivot toward artificial intelligence-powered customer acquisition and engagement solutions. The transformation follows the acquisition of AI Maverick Intel, a platform specializing in AI-based audience automation and intelligent two-way communication. The company aims to deploy its proprietary technology across healthcare, biotech, and other sectors to enhance targeting, engagement, and operational efficiency.  To view the full press release, visit https://nnw.fm/J6I3z  About Bionoid Pharma Inc.  Bionoid Pharma Inc. is a forward-thinking company focused on leveraging artificial intelligence to unlock new commercial opportunities and improve digital engagement. With a…

Continue Reading

FridayMay 16, 2025 10:00 am

NetworkNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Expands to Indonesia with AI Insurance Platform Through Mach Wireless Deal

FingerMotion (NASDAQ: FNGR), has entered the Indonesian market via its subsidiary, Finger Motion Financial Company Limited, by signing an agreement with PT Mach Wireless Teknologi to deploy its AI-driven insurance risk rating platform. Tailored for local underwriting in motor, health, and life insurance, the platform will integrate with Indonesia’s telco-insurance ecosystem. The company is in final talks with a major Indonesian telecom provider to support the rollout. This marks a key milestone in FingerMotion's Southeast Asia expansion strategy, blending AI, big data, and regional partnerships to transform digital insurance delivery. To view the full press release, visit https://nnw.fm/7VaEd About FingerMotion…

Continue Reading

FridayMay 16, 2025 9:00 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q1 Results, Highlights Progress on Ketamine NDA and HOPE Clinic Rollup 

NRx Pharmaceuticals (NASDAQ: NRXP) reported a Q1 2025 net loss of $5.5 million, down from $6.5 million in the same period last year, with operating losses narrowing to $3.8 million. The company advanced regulatory and commercial milestones for its two lead programs: NRX-100, a preservative-free IV ketamine formulation for suicidal depression now supported by an NDA fee waiver and new patent filing; and NRX-101, an oral treatment for bipolar depression with a PDUFA date anticipated before year-end. Subsidiary HOPE Therapeutics also gained momentum with $10.3 million in new acquisition funding to support a national psychiatry clinic rollup. NRx ended the…

Continue Reading

FridayMay 16, 2025 9:00 am

NetworkNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) CEO Highlights Vertical Integration and $184M Asset Base on GotStocks Podcast

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (CSE: SUNN) President and CEO Dr. Richard Lu appeared on the GotStocks Podcast to discuss the company’s vertically integrated model and its $184 million portfolio of revenue-generating clean energy assets. Lu detailed how SolarBank develops, builds, owns, and operates distributed and community solar projects across Canada and the U.S., including partnerships with Honeywell and Qcells. He also highlighted a recent $100 million financing agreement with CIM Group to fund 97 MW of U.S. projects, positioning the company for continued long-term growth. To view the full press release, visit https://nnw.fm/V7HaW About SolarBank…

Continue Reading

ThursdayMay 15, 2025 2:28 pm

NetworkNewsBreaks – Zacks Research Issues Business Update as Soligenix Inc. (NASDAQ: SNGX) Continues Enrollment in Confirmatory Phase 3 HyBryte Trial 

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted this week in a Zacks Small-Cap Research report that presented a favorable analysis, noting that the company’s Phase 3 cutaneous T-cell lymphoma (“CTCL”) study is continuing and that the trial has a high probability of success.  According to the report, Soligenix is conducting a Phase 3 FLASH2 trial of HyBryte(TM) in patients with CTCL. The Zacks report noted that the FLASH2 trial is similar in design to the recently completed successful Phase 3 FLASH trial. The one key difference between the trials is that in the FLASH trial…

Continue Reading

ThursdayMay 15, 2025 12:37 pm

NetworkNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally

Intelligent Bio Solutions (NASDAQ: INBS)  reported continued commercial growth, surpassing 450 active accounts with 35 added in fiscal Q3, driven by demand for its rapid, non-invasive fingerprint drug testing system. The company expanded into new sectors including luxury marine, retail, and waste management, while entering remote regions across Europe and Australia. INBS now operates in 24 countries and partners with 18 distributors across 19 nations. These milestones support the company’s global expansion strategy and position it for entry into the multi-billion-dollar U.S. testing market.  To view the full article, visit https://nnw.fm/tzRUc  About Intelligent Bio Solutions Inc.  Intelligent Bio Solutions Inc.…

Continue Reading